missing translation for 'onlineSavingsMsg'
Learn More

FSTL1 Mouse, anti-Human, Clone: 1G5G1, Proteintech

Mouse Monoclonal Antibody

£135.00 - £349.00

Specifications

Antigen FSTL1
Clone 1G5G1
Concentration 1000 μg/mL
Applications Western Blot, ELISA
Form Liquid
View More Specs

Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
18089465
missing translation for 'viewDocuments'
Proteintech
68528-1-IG-20UL
20 μL
£135.00
20µL
View alternative products
missing translation for 'toSaveUpto' 
»
Please to purchase this item. Need a web account? Register with us today!
18024785
missing translation for 'viewDocuments'
Proteintech
68528-1-IG-150UL
150 μL
£349.00
150µL
View alternative products
missing translation for 'toSaveUpto' 
»
Please to purchase this item. Need a web account? Register with us today!
Description

Description

The FSTL1 antibody from Proteintech is a mouse monoclonal antibody generated with recombinant protein of human FSTL1. This antibody recognizes human, mouse, rat antigen. The FSTL1 antibody has been validated for the following applications: WB, ELISA analysis.

Specifications

Specifications

FSTL1
1000 μg/mL
Liquid
Human, Mouse, Rat
FLJ50214, FLJ52277, follistatin like 1, Follistatin like protein 1, Follistatin related protein 1, FRP, FSL1, FSTL1
Primary
1G5G1
Western Blot, ELISA
Mouse
11167
IgG2a
Store at -20°C. Stable for one year after shipment.
Videos
SDS
Documents

Documents

Certificates
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.